Arkolith/Insider Trading/SAGE/Form 4

Quirk Michael C.

See RemarksSage Therapeutics, Inc. (SAGE) · full profile →Form 4 · filed Apr 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 10, 2025Tax withholding(F)424$6.91$3K31K
Apr 10, 2025Grant(A)933—$030K
Apr 10, 2025Tax withholding(F)312$6.91$2K30K
Apr 10, 2025Grant(A)1K—$031K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-003113) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML